Sensyne Health announces one year agreement with Exscientia to utilise real-world data platform Agreement includes an upfront payment for four SENSIGHT subscriptions and associated professional services Oxford, U.K. – 24th December…
OrganOx receives FDA approval for metra device OrganOx, a world leader in normothermic machine perfusion (NMP), today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of…
The Oxford Science Park Innovation Award returns as Oxfordshire Business Awards resume Apply now to join previous winners – Oxford Space Systems, Perspectum Diagnostics, Adaptix & Oxford Biomedica Oxford, UK,…
The Oxford Science Park and its occupiers gathered together recently to celebrate successes and progress over recent months – a period in which the importance of science and technology companies in…
Oxford, UK – 10 November 2021 – Sitryx (“the Company”), a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in immuno-inflammation and immuno-oncology, today announces the appointment…
OMass Unveils Rich Drug Discovery Pipeline Targeting Intractable or Inadequately Drugged Membrane and Complex-bound Proteins Oxford, United Kingdom – 4 November 2021 – OMass Therapeutics (‘OMass’ or ‘the Company’), a…
Acquisition of ATDBio by Biotage AB to provide platform for further growth Founders look forward to continued focus on customers and innovation Oxford and Southampton, UK, October 20 2021 –…
Scancell expands its R&D capabilities with new facilities at The Oxford Science Park Oxford, UK, 19 October 2021 – Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for…
LANDMARK PAPER HIGHLIGHTS EVOX THERAPEUTICS’ CUTTING EDGE EXOSOME ENGINEERING APPROACH FOR ENHANCED SURFACE DISPLAY OF BIOLOGICS Evox’s engineered exosomes show better efficacy compared to conventional biologics and significantly outperformed other…
Magdalen College & GIC enter Strategic Partnership to accelerate development of The Oxford Science Park Investment initiates transformational construction programme as demand for life sciences & technology space continues…
Vatic announces manufacturing partnership with Abingdon Health Abingdon Health plc (“Abingdon Health”), a leading international developer and manufacturer of high quality and effective rapid tests, and Vatic Health Limited (“Vatic”),…
OXFORD, England–(BUSINESS WIRE)– Exscientia plc (Nasdaq: EXAI), an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner, today announced the…
Physiomics plc (AIM: PYC), the consultancy using mathematical models to support the development of drug treatment regimens and personalised medicine solutions is pleased to announce its PARTNER study has recruited…
DR. CAROLIN BARTH JOINS MIROBIO AS CEO TO LEAD PRECISION IMMUNOLOGY COMPANY FOCUSED ON CHECKPOINT AGONIST ANTIBODIES Former Novartis executive to lead emerging biotech with a novel precision approach to…
Exscientia enters $70M collaboration to develop anti-viral therapeutics against Coronavirus and other viruses with pandemic potential Four-year agreement with Bill & Melinda Gates Foundation to discover and develop small molecule…
